A detailed history of Verdad Advisers, LP transactions in Johnson & Johnson stock. As of the latest transaction made, Verdad Advisers, LP holds 4,808 shares of JNJ stock, worth $747,499. This represents 0.81% of its overall portfolio holdings.

Number of Shares
4,808
Previous 2,925 64.38%
Holding current value
$747,499
Previous $462,000 51.95%
% of portfolio
0.81%
Previous 0.5%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$144.38 - $157.78 $271,867 - $297,099
1,883 Added 64.38%
4,808 $702,000
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $454,018 - $476,014
2,925 New
2,925 $462,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Verdad Advisers, LP Portfolio

Follow Verdad Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdad Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Verdad Advisers, LP with notifications on news.